WASHINGTON, D.C. - Senator Casey questioned the FDA's recent approval of a new painkiller, Zohydro, and asked that the status of naloxone, a drug that reverses heroin overdoses, be reviewed Thursday during a hearing of the Health Education Labor and Pensions Committee.
"Families and communities across Pennsylvania have struggled with the disease of addiction. It's vital that we take steps to help these families, our medical professionals and law enforcement in this effort," Senator Casey said in a news release. "I have serious concern about the FDA's approval of Zohydro and the impact it could have for those struggling with addiction."
Casey also wants the FDA to make lifesaving doses of naloxone more accessible.
According to Casey's new release, the commissioner of the FDA recognized the importance of drugs like naloxone and "pledged to make progress on abuse deterrent technology that could reduce the addictive potential of drugs like Zohydro."
A judge's ruling is increasing the possible penalty that three former Penn State administrators could face if convicted of crimes for how they responded to the Jerry Sandusky child molestation scandal.Read More »
- Sunoco building 2 pipelines, not just 1 across Pennsylvania
- Attorney general says costs related to Kane reached $3.6M
- Republicans eye revenue assumptions in Wolf's budget
- Snow geese migrating earlier due to milder temps
- Local business skeptical of Wolf's proposal to raise minimum wage
- Wolf could secure minimum wage hike, with big concession
- Thursday's record-breaking warmth in Allentown
- Suspect arrested in fatal shooting in Palmer Township
- Good Samaritan recalls stabbing attack
- Woman identified in Allentown hit-and-run
- Mother charged after concealing death of baby
- DOE rolls back transgender bathroom protections
- Easton 20-year plan envisioned
- Taxpayers' cost for Chris Christie security detail tops $2M
- Dunkin' Donuts helping to 'roast' hunger in Berks
- Candidate for Allentown mayor advised not to run